Patents by Inventor Suman Pathi

Suman Pathi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260200908
    Abstract: Provided herein are optionally substituted pyrazolylacetamides, pharmaceutical compositions comprising a therapeutically effective amount of such compounds and a pharmaceutically acceptable excipient, and methods of treating diseases or disorders, such as, epilepsy, amyotrophic lateral sclerosis, various types of pain, hyperexcitability, a dyskinesia, dystonia, mania, tinnitus, neurodevelopmental diseases or disorders, a smooth muscle contractility disorder, Dravet syndrome, posttraumatic stress disorder (PTSD), with such compounds and pharmaceutical compositions.
    Type: Application
    Filed: February 20, 2026
    Publication date: July 16, 2026
    Inventors: Lynn RESNICK, James S. HALE, Charles A. FLENTGE, Suman PATHI, Isis J. AMAYE, David A. MARESKA, James Proviano BURROWS, Jeffrey Claude PELLETIER
  • Publication number: 20250230152
    Abstract: Provided herein are optionally substituted pyrazolylacetamides, pharmaceutical compositions comprising a therapeutically effective amount of such compounds and a pharmaceutically acceptable excipient, and methods of treating diseases or disorders, such as, epilepsy, amyotrophic lateral sclerosis, various types of pain, hyperexcitability, a dyskinesia, dystonia, mania, tinnitus, neurodevelopmental diseases or disorders, a smooth muscle contractility disorder, Dravet syndrome, posttraumatic stress disorder (PTSD), with such compounds and pharmaceutical compositions.
    Type: Application
    Filed: April 1, 2025
    Publication date: July 17, 2025
    Inventors: Lynn RESNICK, James S. Hale, Charles A. Flentge, Suman Pathi, Isis J. Amaye, David A. Mareska
  • Publication number: 20250171430
    Abstract: Provided herein are optionally substituted pyrazolylacetamides, pharmaceutical compositions comprising a therapeutically effective amount of such compounds and a pharmaceutically acceptable excipient, and methods of treating diseases or disorders, such as, epilepsy, amyotrophic lateral sclerosis, various types of pain, hyperexcitability, a dyskinesia, dystonia, mania, tinnitus, neurodevelopmental diseases or disorders, a smooth muscle contractility disorder, Dravet syndrome, posttraumatic stress disorder (PTSD), with such compounds and pharmaceutical compositions.
    Type: Application
    Filed: February 23, 2023
    Publication date: May 29, 2025
    Inventors: Lynn RESNICK, James S. HALE, Charles A. FLENTGE, Suman PATHI, Isis J. AMAYE, David A. MARESKA
  • Publication number: 20250171405
    Abstract: Provided herein are optionally substituted pyrazolylacetamides, pharmaceutical compositions comprising a therapeutically effective amount of such compounds and a pharmaceutically acceptable excipient, and methods of treating diseases or disorders, such as, epilepsy, amyotrophic lateral sclerosis, various types of pain, hyperexcitability, a dyskinesia, dystonia, mania, tinnitus, neurodevelopmental diseases or disorders, a smooth muscle contractility disorder, Dravet syndrome, posttraumatic stress disorder (PTSD), with such compounds and pharmaceutical compositions.
    Type: Application
    Filed: February 23, 2023
    Publication date: May 29, 2025
    Inventors: Lynn RESNICK, Isis J. AMAYE, Suman PATHI, James S. HALE
  • Publication number: 20250171429
    Abstract: Provided herein are optionally substituted pyrazolylacetamides, pharmaceutical compositions comprising a therapeutically effective amount of such compounds and a pharmaceutically acceptable excipient, and methods of treating diseases or disorders, such as, epilepsy, amyotrophic lateral sclerosis, various types of pain, hyperexcitability, a dyskinesia, dystonia, mania, tinnitus, neurodevelopmental diseases or disorders, a smooth muscle contractility disorder, Dravet syndrome, posttraumatic stress disorder (PTSD), with such compounds and pharmaceutical compositions.
    Type: Application
    Filed: February 23, 2023
    Publication date: May 29, 2025
    Inventors: Lynn RESNICK, James S. HALE, Charles A. FLENTGE, Suman PATHI, Isis J. AMAYE, David A. MARESKA